Elisabeth Krug

Executive Director, BRD Analytical Development at Eli Lilly & Company

Speaker

Dr. Elisabeth Krug serves as an Executive Director at Eli Lilly and Company. She brings 30 years of experience in small and large molecule analytical development, supporting activities from preclinical to BLA/NDA. Elisabeth graduated as a pharmaceutical biologist from the University of Wuerzburg, Germany and joined Lilly Hamburg in 1995 as an analytical scientist. After four years as a Black Belt in the company’s Six Sigma program she graduated as a Master Black Belt in 2010. She then joined the large molecule analytical development group and took an interim assignment to head the bioassay development group. Elisabeth has been extensively working with biomolecules, responsible for defining and delivering on the analytical control strategy.